Naprosyn Ec (Naproxen)

Naproxen, the active ingredient in Naprosyn Ec, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is used to relieve mild to moderate pain, reduce inflammation, and lower fever in a variety of adult patients.

GNH USA supplies Naprosyn Ec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naprosyn Ec is an NSAID that acts on inflammatory and pain pathways in several musculoskeletal and gynecologic conditions.

- Mild to moderate pain: provides analgesic relief for headaches, dental pain, and minor injuries. - Rheumatoid arthritis: helps control joint inflammation and stiffness. - Osteoarthritis: reduces chronic joint pain and improves mobility. - Musculoskeletal pain: alleviates strain, sprain and back pain. - Dysmenorrhea: eases menstrual cramps and associated discomfort.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: dyspepsia, nausea, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Elevated blood pressure. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Severe renal impairment or failure. - Hepatic injury or elevated liver enzymes. - Life‑threatening skin reactions (e.g., Stevens‑Johnson syndrome). - Anaphylaxis or severe hypersensitivity reactions.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly. - Assess gastrointestinal risk: review history of ulcers, bleeding, or chronic NSAID use. - Evaluate cardiovascular profile: consider existing heart disease or risk factors. - Monitor renal function: especially in patients with dehydration or pre‑existing kidney disease. - Use the lowest effective dose for the shortest duration needed. - Avoid use in patients with known hypersensitivity to naproxen or other NSAIDs. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Naproxen can alter the pharmacodynamics or pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function. - Lithium: naproxen may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal perfusion when combined. - Corticosteroids: increased risk of gastrointestinal ulceration. - Methotrexate: potential for elevated methotrexate levels. - Antihypertensives (e.g., beta‑blockers): possible attenuation of blood pressure control. - Oral hypoglycemics: naproxen may affect glucose control.